Suppr超能文献

霍乱全毒素组装在A-B5界面需要一个疏水结构域:突变分析及体外组装系统的开发

Cholera holotoxin assembly requires a hydrophobic domain at the A-B5 interface: mutational analysis and development of an in vitro assembly system.

作者信息

Tinker Juliette K, Erbe Jarrod L, Hol Wim G J, Holmes Randall K

机构信息

Department of Microbiology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.

出版信息

Infect Immun. 2003 Jul;71(7):4093-101. doi: 10.1128/IAI.71.7.4093-4101.2003.

Abstract

Cholera toxin (CT) and related Escherichia coli enterotoxins LTI and LTIIb have a conserved hydrophobic region at the AB(5) interface postulated to be important for toxin assembly. Hydrophobic residue F223 in the A subunit of CT (CTA) as well as residues 174, L77, and T78 in the B subunit of CT (CTB) were replaced individually with aspartic acid, and the resulting CTA and CTB variants were analyzed for their ability to assemble into holotoxin in vivo. CTA-F223D holotoxin exhibited decreased stability and toxicity and increased susceptibility to proteolysis by trypsin. CTB-L77D was unable to form functional pentamers. CTB-I74D and CTB-T78D formed pentamers that bound to GM(1) and D-galactose but failed to assemble with CTA to form holotoxin. In contrast, CTB-T78D and CTA-F223H interacted with each other to form a significant amount of holotoxin in vivo. Our findings support the importance of hydrophobic interactions between CTA and CTB in holotoxin assembly. We also developed an efficient method for assembly of CT in vitro, and we showed that CT assembled in vitro was comparable to wild-type CT in toxicity and antigenicity. CTB-I74D and CTB-T78D did not form pentamers or holotoxin in vitro, and CTA-F223D did not form holotoxin in vitro. The efficient system for in vitro assembly of CT described here should be useful for future studies on the development of drugs to inhibit CT assembly as well as the development of chimeric CT-like molecules as potential vaccine candidates.

摘要

霍乱毒素(CT)以及相关的大肠杆菌肠毒素LTI和LTIIb在AB(5)界面处有一个保守的疏水区域,据推测该区域对毒素组装很重要。将CT的A亚基(CTA)中的疏水残基F223以及CT的B亚基(CTB)中的残基174、L77和T78分别替换为天冬氨酸,并分析所得的CTA和CTB变体在体内组装成全毒素的能力。CTA-F223D全毒素表现出稳定性和毒性降低,对胰蛋白酶的蛋白水解敏感性增加。CTB-L77D无法形成功能性五聚体。CTB-I74D和CTB-T78D形成了与GM(1)和D-半乳糖结合的五聚体,但未能与CTA组装形成全毒素。相比之下,CTB-T78D和CTA-F223H在体内相互作用形成了大量的全毒素。我们的研究结果支持了CTA和CTB之间疏水相互作用在全毒素组装中的重要性。我们还开发了一种在体外组装CT的有效方法,并且我们表明体外组装的CT在毒性和抗原性方面与野生型CT相当。CTB-I74D和CTB-T78D在体外不形成五聚体或全毒素,而CTA-F223D在体外不形成全毒素。本文所述的CT体外有效组装系统应有助于未来关于开发抑制CT组装的药物以及开发作为潜在疫苗候选物的嵌合CT样分子的研究。

相似文献

4
Protein-disulfide isomerase displaces the cholera toxin A1 subunit from the holotoxin without unfolding the A1 subunit.
J Biol Chem. 2011 Jun 24;286(25):22090-100. doi: 10.1074/jbc.M111.237966. Epub 2011 May 4.
7
Engineering of cholera toxin A-subunit for carriage of epitopes at its amino end.
FEBS Lett. 1997 Jan 13;401(1):95-7. doi: 10.1016/s0014-5793(96)01445-7.
10
The affinity of cholera toxin for Ni2+ ion.
Protein Eng. 1998 Jul;11(7):577-81. doi: 10.1093/protein/11.7.577.

引用本文的文献

1
The Mutagenic Plasticity of the Cholera Toxin B-Subunit Surface Residues: Stability and Affinity.
Toxins (Basel). 2024 Mar 4;16(3):133. doi: 10.3390/toxins16030133.
2
Characterization and utility of two monoclonal antibodies to cholera toxin B subunit.
Sci Rep. 2023 Mar 15;13(1):4305. doi: 10.1038/s41598-023-30834-2.
3
Cell-Free Systems Enable the Production of AB Toxins for Diagnostic Applications.
Toxins (Basel). 2022 Mar 23;14(4):233. doi: 10.3390/toxins14040233.
4
Engineering an AB Protein Carrier.
Sci Rep. 2018 Aug 23;8(1):12643. doi: 10.1038/s41598-018-30910-y.
5
Immunogenicity of a Staphylococcus aureus-cholera toxin A/B vaccine for bovine mastitis.
Vaccine. 2018 Jun 7;36(24):3513-3521. doi: 10.1016/j.vaccine.2018.04.067. Epub 2018 May 5.
6
Modeling the assembly order of multimeric heteroprotein complexes.
PLoS Comput Biol. 2018 Jan 12;14(1):e1005937. doi: 10.1371/journal.pcbi.1005937. eCollection 2018 Jan.
8
Structural basis of subtilase cytotoxin SubAB assembly.
J Biol Chem. 2013 Sep 20;288(38):27505-27516. doi: 10.1074/jbc.M113.462622. Epub 2013 Aug 6.
10

本文引用的文献

1
A kinetic model of intermediate formation during assembly of cholera toxin B-subunit pentamers.
J Biol Chem. 2002 May 10;277(19):16697-704. doi: 10.1074/jbc.M110561200. Epub 2002 Mar 4.
3
Cholera. A toxin with emerging therapeutic potential.
Lancet. 2001 Dec;358 Suppl:S7. doi: 10.1016/s0140-6736(01)07020-9.
5
In vitro assembly of novel cholera toxin-like complexes.
Anal Biochem. 2001 May 15;292(2):171-7. doi: 10.1006/abio.2001.5084.
6
AB(5) toxins: structures and inhibitor design.
Curr Opin Struct Biol. 2000 Dec;10(6):680-6. doi: 10.1016/s0959-440x(00)00152-4.
8
Membrane traffic and the cellular uptake of cholera toxin.
Biochim Biophys Acta. 1999 Jul 8;1450(3):177-90. doi: 10.1016/s0167-4889(99)00070-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验